Prevalence of vulvovaginal candidiasis among pregnant women in Africa: A systematic review and meta-analysis

AO Mohamed, MS Mohamed, TH Mallhi… - The Journal of Infection …, 2022 - jidc.org
Introduction: Vulvovaginal candidiasis (VVC) is a yeast infection of the vulva, which is
caused by Candida species and affects women worldwide. Pregnant women are more …

Prevalence of vulvovaginal candidiasis in Brazil: a systematic review

GC Carvalho, RAP De Oliveira, VHS Araujo… - Medical …, 2021 - academic.oup.com
Vulvovaginal candidiasis (CVV) is a condition in which signs and symptoms are related to
inflammation caused by Candida spp infection. It is the second leading cause of vaginitis in …

Antifungal susceptibility pattern of Candida species isolated from pregnant women

M Ali, WH Edrees, WA Al-Shehari, G Xue… - Frontiers in Cellular …, 2024 - frontiersin.org
Introduction Candida species, opportunistic yeast, are the second most common cause of
female vulvovaginal candidiasis. This study aimed to evaluate the antifungal susceptibility …

Phytolectin nanoconjugates in combination with standard antifungals curb multi-species biofilms and virulence of vulvovaginal candidiasis (VVC) causing Candida albicans and …

J Senthilganesh, S Kuppusamy, R Durairajan… - Medical …, 2022 - academic.oup.com
Vulvovaginal candidiasis (VVC) is a commonly occurring yeast infection caused by Candida
species in women. Among Candida species, C. albicans is the predominant member that …

Vulvovaginal candidiasis, an increasing burden to women in the tropical regions attending Bharatpur Hospital, Chitwan

A Subedi, MK Upreti, JC Rana, RP Sapkota… - Journal of Medical …, 2024 - Elsevier
Vulvovaginal candidiasis is a yeast infection commonly caused by the overgrowth of
Candida species in and around the vulva and vagina. Abnormal vaginal discharge, itching …

[HTML][HTML] Abnormal M1 polarization of placental macrophage induced by IL-15/STAT5 activation in VVC may lead to adverse pregnancy outcomes

Y Zhang, L Zhao, A Wu, P Lin, J Fan, J Chen… - Microbes and …, 2024 - Elsevier
Pregnant women with vulvovaginal candidiasis (VVC) may experience adverse pregnancy
outcomes such as premature delivery, intrauterine infection, abortion, and neonatal …

Efficacy of lipid nanoparticles-based vaccine to protect against vulvovaginal candidiasis (VVC): Implications for women's reproductive health

MA Khan, AM Mousa, AE Alradhi, K Allemailem - Life Sciences, 2025 - Elsevier
Aims Vulvovaginal candidiasis (VVC) is a common women's health issue, with rising
antifungal resistance. This study was aimed to prepare and evaluate the efficacy of a lipid …

Risks for Recurrent Vulvovaginal Candidiasis Caused by Non-Albicans Candida Versus Candida Albicans

A Boyd Tressler, M Markwei, C Fortin… - Journal of Women's …, 2021 - liebertpub.com
Background: Vulvovaginal candidiasis (VVC) is the second most common vulvovaginitis
(VV). About 20% of women will experience recurrent infections in their lifetime with non …

[HTML][HTML] Mitigating a Widespread Burden: Chitosan Hydrogels and De-rivatives as an Ecologically Responsible Delivery Approach for Vulvovaginal Candidiasis

R Basawa, S Kabra, R Raval - Carbohydrate Polymer Technologies and …, 2024 - Elsevier
An abundance of factors such as a high recurrence rate, antibiotic resistance, and the
advent of persistent strains contribute to the continual threat that vulvovaginal candidiasis …

Assessment of risk factors for developing vulvovaginal candidiasis among women at various age groups

VR Irene, CI Sajeeth, V Karthikeyan - Biosciences Biotechnology …, 2023 - biotech-asia.org
Vulvovaginal candidiasis (VVC) is the second most frequent vaginal infection in women and
occurs as an opportunistic infection generally caused by Candida albicans. The objective of …